The EHS Plan for Excellence
|
|
 |
Early in 2003 we published our strategic approach to environment,
health and safety, the EHS Plan for Excellence. The EHS Plan for Excellence
shows how GlaxoSmithKline's environment, health and safety framework
aligns with the company's vision, strategic intent and key business
drivers. It shows how GlaxoSmithKline will progress through management
systems to leadership and excellence.
In the EHS Plan for Excellence we enunciate our long-term aspirations
for environment, health and safety. Though we recognise that it
may be difficult to deliver these aspirations quickly, they will
guide the global organisation through the implementation of environment,
health and safety management systems to leadership and towards sustainability
during the period up to 2010.
To help focus global environment, health and safety efforts on
key strategic issues and draw attention to a progressive evolution
from managing our key risks to advancing our sustainability, the
plan calls for a yearly theme to be set. We have projected themes
for the years until 2010, but these recommendations will adjust
year by year to take into account current business circumstances,
long-term business direction and emerging issues.
In 2003, we focused on improving programmes to protect the health
and safety of our employees in a number of areas that risk assessment
had identified as key. The progress made is reflected in our improved
lost time injury and illness
performance. These improvement efforts will continue in 2004.
In 2004 our main focus will be responding to external EHS challenges.
Recognising the societal concerns about the possible long term impacts
of industry on the environment and the trend towards greater environmental
regulation, we will evaluate the issues and consider GlaxoSmithKline's
position on some key topics. In particular, we will consider:
-
concerns about the possible effects of pharmaceuticals in the
environment
-
developments in chemicals policy which could affect the use
of some materials in the long term
-
the future use of energy and its implications for greenhouse
gas emissions leading to climate change
We will also implement a regulatory tracking process to ensure
that GlaxoSmithKline management stays alert to emerging environment,
health and safety issues that could affect the business.
Since the formation of GSK we have had annual themes and objectives.
This list demonstrates progress we have made and where we want to
go.
EHS Theme for 2001: Laying
the Foundations
Specific objectives:
-
Implement a new GlaxoSmithKline EHS organisation
-
Define the GlaxoSmithKline EHS strategy
-
Integrate EHS management systems from the heritage
companies
-
Establish EHS improvement targets
-
Involve internal stakeholders
|
EHS Theme for 2002: Building
the Framework
Specific objectives:
-
Develop programme implementation plans and schedules
-
Develop GlaxoSmithKline EHS guidelines and the audit
programme
-
Launch an intranet system to support EHS programmes
-
Measure improvements against EHS targets
-
Launch the CEO's EHS Excellence Awards
-
Establish a dialogue with external stakeholders
|
EHS Theme for 2003: Reducing
Key EHS Risks
Specific objectives:
-
Initiate a driver safety programme
-
Assess occupational chemical exposures
-
Develop tools to manage stress and ergonomics
-
Enhance process safety focus and tools
-
Ensure site emergency plans are in place
-
Provide tools for new product development
|
EHS Theme for 2004: Responding
to External EHS Challenges
Specific objectives:
-
Draft a policy on pharmaceuticals in the environment
-
Draft a policy on the use of chemicals
-
Draft a policy on the future use of energy
-
Implement a regulatory tracking system for EHS
|
|
